✦ LIBER ✦
Reductions in Fecal Calprotectin and Lactoferrin Following Ustekinumab Induction Therapy in Patients With Moderate to Severe Crohn's Disease Who Have Previously Failed or Been Intolerant of TNF Antagonist Therapies
✍ Scribed by Toedter, Gary ;Wu, Xiaoying ;Gao, Long-Long ;Gasink, Christopher
- Book ID
- 122114950
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 94 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.